ニュートン バイオキャピタル、和田 道彦博士とフィリップ デバッカー博士の参画で、チーム体制をさらに強化 Newton Biocapital Nov 07, 2022 13:00 JST Read More
エーザイ、筋緊張改善剤「ミオナール(R)」、めまい・平衡障害治療剤「メリスロン(R)」についてアジアにおける権利をDKSHに譲渡 Eisai Nov 07, 2022 08:30 JST Read More
Eisai to Divest Rights for Muscle Relaxant Myonal, Vertigo, and Equilibrium Disturbance Treatment Merislon in Asia to DKSH Eisai Nov 07, 2022 08:15 HKT/SGT Read More
エーザイ、タイにおいてThai Life Insuranceとアルツハイマー病をはじめとする認知症の治療に対するアクセス支援に向けた協働について合意 Eisai Nov 04, 2022 16:00 JST Read More
Eisai's Sales Subsidiary Collaborates with Thai Life Insurance to Support Access to Treatments for Dementia, Including Alzheimer's Disease, in Thailand Eisai Nov 04, 2022 14:42 HKT/SGT Read More
Eisai Satisfies All-case Study Requirement for Antiepileptic Agent Inovelon Eisai Nov 02, 2022 17:34 HKT/SGT Read More
Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination Eisai Nov 02, 2022 09:43 HKT/SGT Read More
エーザイ、「アリセプト(R)」について日本のレビー小体型認知症に係る適応に関する再審査結果に伴う用法・用量の一部変更申請の予定について発表 Eisai Oct 31, 2022 17:00 JST Read More
ClinicalSquared Partners with Solve.Care to Create Web3 Health Networks on the Blockchain Solve.Care Oct 11, 2022 08:20 JST Read More
Olympus EU-ME3 Ultrasound Processor, Delivers Higher Resolution Images for Endoscopic Ultrasound Olympus Oct 07, 2022 14:00 HKT/SGT Read More
Eisai Completes Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan Eisai Oct 04, 2022 15:44 HKT/SGT Read More
Olympus Launches THUNDERBEAT Energy Device for Open Surgery Olympus Sep 30, 2022 10:00 HKT/SGT Read More
アバンセ・クリニカルがInternational Health AwardのBiotech CRO Services部門で受賞 Avance Clinical Sep 29, 2022 12:00 JST Read More
Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint Eisai Sep 28, 2022 14:15 HKT/SGT Read More
HMA conference to look at future of Hospital at Home model in Asia Clarion Events Ltd Sep 28, 2022 09:54 JST Read More
エーザイ、レカネマブがグローバル大規模臨床第III相CLARITY AD検証試験で統計学的に高度に有意な臨床症状の悪化抑制を示し、主要評価項目を達成 Eisai Sep 28, 2022 09:00 JST Read More
Eisai: Metoject Subcutaneous Injection Syringe (Methotrexate) Approved in Japan for Rheumatoid Arthritis Eisai Sep 26, 2022 19:14 HKT/SGT Read More
エーザイ：「メトジェクト(R) 皮下注シリンジ」（一般名：メトトレキサート）が日本において関節リウマチに係る製造販売承認を取得 Eisai Sep 26, 2022 15:00 JST Read More
